Posted on 1/3/18
Dr. John Mendlein Joins Moderna as President, Corporate and Product Strategy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Posted on 1/3/18
Syntimmune Appoints Jean-Paul Kress, M.D., as CEO
WALTHAM, Mass.--(BUSINESS WIRE)--Syntimmune, Inc., a clinical-stage biotechnology company focused on FcRn biology, today announced that the company has appointed Jean-Paul Kress, M.D., as President and Chief . . .
Posted on 1/3/18
Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals announced the appointment of Peter Ho, MD, PhD, as Chief Medical Officer. Dr. Ho joins Boston Pharmaceuticals from Epizyme, where as Chief . . .
Posted on 1/3/18
Watermill Group Sells C&M Corp. to Snow Phipps-owned Winchester Interconnect
The Watermill Group, LLC, a strategy-driven private investment firm, today announced the sale of C&M Corporation to
Posted on 1/3/18
Dr. Xiaoxiang Chen Joins Harbour BioMed as EVP
SHANGHAI, ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today the appointment of Dr. Xiaoxiang Chen as Executive Vice President, Head of Clinical Development and . . .
Posted on 1/3/18
Proclara Biosciences Appoints David Michelson, M.D., as Chief Medical Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced the appointment of David Michelson, M.D., as chief . . .
Posted on 1/3/18
Jim Kelliher Joins Drift as CFO
BOSTON--(BUSINESS WIRE)--Drift, the world’s first and only conversational marketing and sales platform, today announced that Jim Kelliher has joined as the company’s first Chief Financial Officer. . . .
Posted on 1/3/18
Symbiotix Biotherapies Announces Process Development & Manufacturing Agreement with Paragon Bioservices
BOSTON--(BUSINESS WIRE)--Symbiotix Biotherapies, Inc. (“Symbiotix”), a pioneering venture-backed microbiome company developing novel molecular therapeutics based on the human microbiome, today announced that it has entered into . . .
Posted on 1/3/18
Desktop Metal Awarded Seminal Separable Supports Patents for Its Metal 3D Printing Technology
BURLINGTON, Mass.--(BUSINESS WIRE)--Desktop Metal, the company committed to bringing metal 3D printing to engineers and manufacturers, announced it has been granted seminal patents by the United . . .
Posted on 1/3/18
South Shore Chamber of Commerce and South Shore Young Professionals to Hold January 16th Coffee Connections in partnership with Liberty Bay Credit Union
The South Shore Chamber of Commerce and its affiliate The South Shore Young Professionals will co-host a Coffee Connections in partnership with Chamber member Liberty Bay . . .
Posted on 1/3/18
Shepley Bulfinch’s Carole C. Wedge, FAIA, LEED AP Joins Boston Green Ribbon Commission
Shepley Bulfinch, a national architecture firm known for design excellence and innovation with offices in Boston, Houston and
Posted on 1/3/18
Scholar Rock Announces $47 Million Series C Financing
SRK-015 to move into clinical development for Spinal Muscular Atrophy (SMA) in first half of 2018; development in additional neuromuscular disorders to followNovel TGF beta 1 . . .
Posted on 1/3/18
NKF Boston Adds Industrial Team with Four Prominent New Hires
Newmark Knight Frank (NKF) is pleased to announce that industry veterans Rick Schuhwerk, Ed Jarosz, Anthony Coskren and Brian Pinch have joined the firm’s Boston office . . .
Posted on 1/3/18
resTORbio Appoints Lynne Sullivan to Its Board of Directors
resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases
Posted on 1/3/18
W.E. Donoghue & Co. Acquires JAForlines Global
W.E. Donoghue & Co., LLC, an investment firm specializing in defensive tactical strategies, today announced the definitive agreement to acquire JAForlines Global, LLC
Posted on 1/3/18
3 Best Big Pharma Stocks to Buy for 2018
If you're expecting massive revenue growth for 2018 among big pharma stocks, think again. Despite hot new drugs for several major drugmakers, many of them also . . .
Posted on 1/3/18
Could iRobot Corporation Be a Millionaire-Maker Stock?
2017 has been a year of ups and downs for iRobot (NASDAQ:IRBT) stockholders -- big ups, and even bigger downs.iRobot hit its high-water mark for the . . .
Posted on 1/3/18
3 Reasons Why 2018 Could Be Berkshire Hathaway's Best Year Yet
A new year brings new opportunity for Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B). It's my view that 2018 could be the company's best year yet, as three major trends . . .
Posted on 1/3/18
Priceline: The Price Is Right
As we head into 2018 with stocks at all-time highs, investors are becoming increasingly more careful with names that have raced to record valuations in 2017. . . .
Posted on 1/3/18
General Electric's Crown Jewel
General Electric (GE) owns a powerhouse. Though news related to the company has been bearish for investors in recent months, some parts of the enterprise are . . .
Posted on 1/3/18
Should You Buy Bristol-Myers Squibb Stock in 2018?
Bristol-Myers Squibb (NYSE:BMY), in many ways, has led the immuno-oncology revolution with its game-changing checkpoint inhibitors Opdivo and Yervoy. However, the stock has lost a bit . . .
Posted on 1/3/18
Could Priceline Group Really Be a Value Stock?
Value investors like bargains. At first glance, leading online travel website specialist Priceline Group (NASDAQ:PCLN) might seem like the opposite of a bargain, with a share . . .
Posted on 1/3/18
Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, . . .
Posted on 1/3/18
Choate Elects Emily Hodge and Dr. Rolando Medina to Partnership
BOSTON, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Choate today announced that Emily Hodge and Dr. Rolando Medina have been elevated to partner, effective January 1, 2018.As . . .
Posted on 1/3/18
Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan
Selecta Biosciences, Inc.(NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies
Boston
